| ID | 118985 |
| 著者 |
板東, 浩
Tokushima University|Medical Research|Japan Low Carbohydrate Diet Promotion Association|Hayashi Hospital
KAKEN研究者をさがす
Hayashi, Kenji
Hayashi Hospital
Sumitomo, Kyoko
Hayashi Hospital
Miki, Kazuya
Hayashi Hospital
Kamoto, Asami
Hayashi Hospital
|
| キーワード | Oral Semaglutide
Rybelsus
Sodium N-(8-[2-Hydroxybenzoyl] Amino) Caprylate
Geriatric Depression Scale
Mirtazapine
Noradrenergic and Specific Serotonergic Antidepressant
Multiple Meta-Analyses of New Generation Antidepressants Study
|
| 資料タイプ |
学術雑誌論文
|
| 抄録 | Background: Oral semaglutide (Rybelsus) has been in focus for type 2 diabetes (T2D).
Case Presentation: The patient is a 73-year-old male with T2D treated with metformin, Ipragliflozin, and rosuvastatin. He was diagnosed with depression by the Geriatric depression scale (GDS) with a stable condition by mirtazapine. His diabetic control was exacerbated to HbA1c 8.8% and weight 63.5kg in Feb 2022. Results: He started to take Rybelsus, and then clinical improvement was found as HbA1c 6.9% and weight 57.5kg for 4 months. Discussion: Remarkable effect of HbA1c and weight may be from longer fasting time after post-med, and regular lifestyle from the stable psychosomatic situation. |
| 掲載誌名 |
Asploro Journal of Biomedical and Clinical Case Reports
|
| ISSN | 25820370
|
| 出版者 | Asploro
|
| 巻 | 5
|
| 号 | 2
|
| 開始ページ | 73
|
| 終了ページ | 78
|
| 発行日 | 2022-07-23
|
| 権利情報 | This is an open-access article distributed under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.
|
| 出版社版DOI | |
| 出版社版URL | |
| フルテキストファイル | |
| 言語 |
eng
|
| 著者版フラグ |
出版社版
|
| 部局 |
医学系
|
